Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation
HFX AdaptivAI combines insights from over 100,000 patients andmore than 100 million data points¹ and leverages artificial intelligence (AI)to deliver responsive and personalized pain relief in real time* Nevro Corp. (NYSE:NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the U.S. Food and Drug […]